CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Electrographic Flow™ Mapping using Ablamap® Software and FIRMap™ Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06260670
NCT06260670N/ACompleted
CompareCT.gov

Electrographic Flow Mapping Electrogram Validation in Patients With Persistent Atrial Fibrillation (FLOW EVAL-AF)

Ablacon, Inc.·interventional·Posted Feb 15, 2024·Updated Apr 10, 2025

In Brief

A clinical study evaluating Electrographic Flow™ Mapping using Ablamap® Software and FIRMap™ Catheter for Persistent Atrial Fibrillation and 3 related conditions. Completed, enrolled 10 participants across 1 site.

Detailed Summary

FLOW EVAL-AF is a prospective, observational, single center pilot trial. The FLOW EVAL-AF trial is designed to identify driver sources in patients with persistent or longstanding persistent AF using EGF mapping and describe the activation patterns observed from concomitant high density mapping of those regions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPersistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation, Atrial Fibrillation, Persistent, Arrhythmias, Cardiac
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedFeb 15, 2024
Enrollment StartSep 1, 2022
Primary CompletionOct 28, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.4 years ago

Interventions

Electrographic Flow™ Mapping using Ablamap® Software and FIRMap™ Catheterdevice

Subjects will receive ElectroGraphic Flow™ (EGF) mapping with Ablamap® Software and a commercially available 64-pole basket mapping catheter (FIRMap™ Catheter, Abbott Laboratories, Abbott park, IL). The FIRMap™ catheter will be inserted into the right and left atrium to acquire 1 minute recordings of electrical signals in several standardized positions, and turn these into electrographic flow (EGF) maps. Subjects will receive concomitant high density (HD) electroanatomical mapping of these regions with the commercially available Ensite Precision mapping system and Advisor™ HD Grid mapping catheter (Abbott Laboratories, Abbott Park, IL).